About Emefcy
Emefcy is a company based in Hadera (Israel) founded in 2007. Emefcy has raised $5 million across 4 funding rounds from investors including True North Venture Partners, Pond Venture Partners and Energy Technology Ventures. Emefcy offers products and services including Sports Betting, Casino Games, Lottery Services, Esports Betting, and Game Slots. Emefcy operates in a competitive market with competitors including Microvi, Bio Huma Netics, Hyfe, Carbogenics and Algal Scientific, among others.
- Headquarter Hadera, Israel
-
Sectors
Environment
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name 6686 Express
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5 M (USD)
in 4 rounds
-
Latest Funding Round
$23.6 M (USD), Post-IPO
Jul 25, 2016
-
Investors
True North Venture Partners
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Emefcy
Emefcy offers a comprehensive portfolio of products and services, including Sports Betting, Casino Games, Lottery Services, Esports Betting, and Game Slots.
Service for betting on global sports events online.
Platform for playing slots, cards, and roulette games.
Tools for lottery predictions and number games.
Betting on competitive video games and tournaments.
Digital slots with jackpots and rewards for players.
Funding Insights of Emefcy
Emefcy has successfully raised a total of $5M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $23.6 million completed in July 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $23.6M
-
First Round
First Round
(11 May 2010)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2016 | Amount | Post-IPO - Emefcy | Valuation |
investors |
|
| Dec, 2012 | Amount | Series C - Emefcy | Valuation |
investors |
|
| Jun, 2011 | Amount | Series B - Emefcy | Valuation |
investors |
Investors in Emefcy
Emefcy has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include True North Venture Partners, Pond Venture Partners and Energy Technology Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage VC firm investing in the US
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Energy technology companies are supported through strategic investments.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Emefcy
Financial Statements - Emefcy
Emefcy Comparisons
Competitors of Emefcy
Emefcy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Microvi, Bio Huma Netics, Hyfe, Carbogenics and Algal Scientific, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biocatalytic solutions for water treatment and purification are provided.
|
|
| domain | founded_year | HQ Location |
Biological compounds are supplied for wastewater treatment and agricultural uses.
|
|
| domain | founded_year | HQ Location |
Provider of bio wastewater services
|
|
| domain | founded_year | HQ Location |
Biochar is manufactured for wastewater treatment applications by Carbogenics.
|
|
| domain | founded_year | HQ Location |
Nutrient recovery from wastewater is enabled via algal processes.
|
Latest news on Emefcy
Frequently Asked Questions about Emefcy
Emefcy was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Emefcy is headquartered in Hadera, Israel. It is registered at Hadera, Central District, Israel.
Emefcy is a funded company, having raised a total of $5M across 4 funding rounds to date.
Founded in 2007, Emefcy operates in the bio-energy sector, focusing on the development and manufacturing of systems that convert wastewater into electricity. Based in Hadera, Israel, the companys technologies are designed for wastewater treatment facilities, enabling energy recovery through biological processes. Operations emphasize sustainable solutions for industrial and municipal applications, with a domain presence at emefcy.com.
Emefcy's top competitors include Bio Huma Netics, Carbogenics and Microvi.
Emefcy offers Sports Betting, Casino Games, Lottery Services, Esports Betting, and Game Slots.
Emefcy has 5 investors. Key investors include True North Venture Partners, Pond Venture Partners, Energy Technology Ventures, Plan², and MoreVC.